This collection will supplement the main collection of the MIA Biospecimen Bank, allowing research into rare melanoma and skin cancer subtypes by NSW researchers in collaboration with national and international colleagues.
What is the issue for NSW?
Melanoma Institute Australia (MIA) biospecimen collection services are vital for numerous clinical and translation research programs. Western Sydney and Regional NSW are not currently within MIA catchment or capabilities, hence many rural NSW patients are not able to participate in clinical trials or research programs which require biospecimen collection.
What the research aims to do and how?
The success of this project is two-fold. It will allow access and improve availability to innovative clinical trials and research programs for rural patients and their clinical teams. It will allow melanoma researchers to study rare melanoma and skin cancer subtypes, including rural patient cohorts in translational research programs and collaborations.